OUR EXPERTISE

We’re a Bench-to-Market Life Science Provider

HEMEX is committed to changing the future of healthcare by guiding the most promising European start-ups through each and every step to bring innovative pharmaceuticals, medical devices and in vitro diagnostics to the market. Headquartered close to the thriving Basel global Life Sciences hub, the goal at HEMEX is to ensure start-ups have access to a wide range of tailored products, practical solutions and fundraising support, either in-house or via our network of pre-qualified experts, laboratories, CMOs, warehouses, logistic partners and affiliates. This empowers the next generation of transformative discoveries to grow into successful and sustainable businesses, and drive change in both human and animal healthcare.

INCUBATOR

Join our successful 6-step incubation program and we’ll coach you all the way on your journey from “green to gold” 

As an experienced team that made pivotal contributions to the approval of several healthcare products, we know exactly what is needed to bring a new product to the market.

Start-ups can enter the program at any stage and no two projects are ever the same.

DREAM

Your journey starts here. Ready to incorporate and not sure about the next steps? Come and see us, we offer an unbeatable one-stop-shop solution!

  • 1-5 founders
  • We give you some first advice for free
  • We help you apply for the Innosuisse coaching program
  • We discuss your financing options and show you how to get there
  • Our in-house notary and accountant will support you with incorporation and setting up your accounts
  • Our IP lawyers advise you on your patents and brands strategy

PLAN

Our lawyer and notary will help you draft all documents and guide you through the process of incorporation.

  • 2-5 first employees
  • You can join our incubator in Liestal (rent-a-desk or full-service virtual office)
  • We discuss with you the best way to get to market approval
  • We help you negotiate a license agreement with the university
  • We help you write a business and development plan
  • We help you find Seed financing
  • We help you with regulatory strategy for EMA and FDA

EXECUTE

Now is the time to put your plans into reality and continue with the product development. HEMEX will help you with all steps that are needed.

  • 5-10 employees
  • We help you with Series A financing
  • We set up your Quality Management System and perform (mock-)audits
  • We partner with you for non-dilutive grants
  • We support your product development with preclinical and clinical operations
  • We help you CE-mark your medical device or get positive CHMP/FDA opinion

SCALE

First sales! Profit is still a bit down the road, though. Scale up is needed, but growing pains are real. We’ll help you go international.

  • 10-50 employees
  • Obtain approval in your first market!
  • We help you with Series B financing
  • We help you develop an international (transfer) pricing strategy
  • We help you develop an approval and reimbursement strategy in the 7MM
  • We help you setting up licensing or co-marketing deals

PROFIT

Your business is sustainable now. Your “baby” has become an adolescent and it’s time to start thinking of letting go!

  • 50-200 employees
  • We help you complementing the founder team with internationally experienced C-level executives who can guide the company through the next stage
  • We help you with market access and insight services in order to boost sales
  • We help you find strategic partners and investors with merger and acquisition capabilities

EXIT

It’s time to reap the fruits of your hard work! We help you with the different options to cash in on your investment.

  • >200 employees
  • We help you implementing your exit strategies
  • Further financing via a co-development or co-marketing partner
  • Trade sale to a larger market player
  • Initial Public Offering

We invest in selected life science start-ups, in cash and/or in kind. 

We combine development and fundraising skills, to offer you a distinctive advantage when interacting with the investor community. We are a knowledgable and reliable partner for investors to oversee their financial commitment. We offer workshops with our in-house accredited Innosuisse special coach to help you with your first financing rounds.

What our start-ups say

Hemex provides Scailyte a range of services, from administrative to highly specialized regulatory and clinical development support. Working at Hemex incubator, whenever we have a question, we can immediately address it. We’re happy to continue our journey with such a trusted partner.

From the start of Resistell, Hemex supports our company in the clinical operations and also back us with its investment arm. The understanding of startup needs, makes Hemex a unique partner in our journey to the market.

Hemex has been instrumental in Annaida Technologies’ progress. They were the first to recognize our potential and acted swiftly to support us in our development. We wouldn’t be where we are without their help.

Hemex supports us in marketing and sales, negotiating with industry partners and regulations. Their team is highly dedicated and delivers always on time and in high quality. Hemex is giving us the support we wished for.

Starting from our first meeting with Hemex, we have gained a lot of value from their life science experience and knowledge. We have received continuous support from Hemex that brought Hi-D Imaging one step further towards our goals.

Hemex provides Scailyte a range of services, from administrative to highly specialized regulatory and clinical development support. Working at Hemex incubator, whenever we have a question, we can immediately address it. We’re happy to continue our journey with such a trusted partner.

From the start of Resistell, Hemex supports our company in the clinical operations and also back us with its investment arm. The understanding of startup needs, makes Hemex a unique partner in our journey to the market.

Hemex has been instrumental in Annaida Technologies’ progress. They were the first to recognize our potential and acted swiftly to support us in our development. We wouldn’t be where we are without their help.

Hemex supports us in marketing and sales, negotiating with industry partners and regulations. Their team is highly dedicated and delivers always on time and in high quality. Hemex is giving us the support we wished for.

Starting from our first meeting with Hemex, we have gained a lot of value from their life science experience and knowledge. We have received continuous support from Hemex that brought Hi-D Imaging one step further towards our goals.

AMT Medical develops a unique coronary bypass system. AMT’s technique enables the bypass surgery to be performed through small holes in the chest. This device has the potential to be the new standard, with lower costs for society, fewer complications, and a faster recovery for the patient.

Annaida Technologies logo

One in 10 couples experiences difficulties conceiving a child. Annaida’s patented NMR technology gives fertility doctors the ability to perform a fast, non-invasive and quantitative embryo screening, providing patients with an improved overall IVF experience.

Swiss startup Artidis Fundraising

The ARTIDISNet platform uses a nanomechanical sensor that captures the physical properties of tissue enabling the clinician to differentiate between benign and malignant tissue from biopsies in cancer patients in under three hours.

Swiss Startup Aspivix Logo Fundraising

ASPIVIX SA is a medical technology company specializing in Women’s Health, which has developed a flagship product called CAREVIX™. This technology is  proprietary vacuum & suction-based. It is used to reduce pain, eliminate bleeding, and tissue tear during gynecological procedures requiring uterus access.

BioReperia logo

BioReperia, based in Sweden and Switzerland, offers a highly precise, humanized zebrafish model to the pharmaceutical industry, to evaluate the safety and efficacy of oncology drug candidates in vivo, getting results as early as within a week.

haako breathe asthma app logo

Haako’s holistic asthma management solution Breathe helps parents of children with asthma. Allowing parents to track and better understand their child’s condition, they can make informed care decisions that achieve better patient outcome for children and less stress to parents.

Swiss Startup Emovo Logo Fundraising

Emovo Care SA has developed the world’s first portable hand orthosis to support care-at-home after a stroke, the Emovo Hand. This product provides a natural sensation of moving the hand to hemiparetic stroke patients to practice functional, comfortable, and intensive exercises directly at home. Emovo’s connected solution will enable to motivate and measure patients’ progress to maximize the outcome of care.

ender provides rapid and reliable testing kits for acute COVID–19 capable of diagnosing multiple samples at once and within just 30 minutes. These tests can be used in hospitals as well as right on-site.

 

Swiss startup GeneLook Fundraising

GeneLook allows patients suffering from rare diseases to access their DNA profile using their smartphone, using it for personalized healthcare and health alerts. In exchange, GeneLook’s business model will also give pharmaceutical companies access to this data to develop new therapies.

GeoHealthApp logo

geoHealthApp GmbH developed an App that has the potential to stop the spread of COVID19. An interactive map shows areas with high infection rates that can be evaded by the user. Based on anonymous smartphone location data and AI, users learn if they have been in contact with infected people during the last 14 days. The Beta Version has been launched in Germany, Switzerland, Austria, UK and USA.

Swiss Startup hexagonFab Logo Fundraising

HexagonFab’s team has developed a new generation of biosensors for rapid and highly sensitive analysis of biomolecules like antibodies, proteins, and small molecules. This award-winning technology, based on graphene nanomaterial, allows pharmaceutical researchers and production staff to monitor biomolecule quality directly at the production line, which offers a $1B market opportunity.

 

Swiss Startup Inura Medical Logo Fundraising

Inura Medical developed a urethral suppository with an approved pharmaceutical agent to help patients  who are suffering from two highly prevalent and disabling health disorders: overactive bladder (OAB) and nocturia.

Hi-D Imaging AG aims to revolutionize the cardiovascular sector by making personalized heart valve replacement therapy a reality. The world’s first AI-based pre-operational planning platform that assesses different heart valves for the patient‘s specific anatomy before the surgery. This technology increases the life quality of the patient and the success rate of the surgery.

Juvabis AG is a spin-off from the University of Zürich and ETH-Zürich, focusing on antimicrobial therapeutic drugs. Juvabis’ most advanced program is apramycin for infusion, a “best-in-class” antibiotic. Apramycin for infusion represents the most successful program within the pan-European ENABLE pipeline of the European Innovative Medicines Initiative.

 

LiVET develops and produces rapid molecular point-of-care diagnostic tests for the veterinary market. Based on LiVET’s proprietary platform technology, veterinarians can diagnose infectious diseases and parasites directly on-site within just 30 minutes. The test kits run on commercially available devices that enables the user to test up to 16 samples at once. This allows for immediate and specific treatment. The first test panel for respiratory diseases in horses includes Strangles, EHV 1+4 and Influenza and will be available in 2020.

Swiss Startup MOMM Diagnostics Logo Fundraising

MOMM Diagnostic’s patented technology is used to early detect a biomarker for pre-eclampsia (PE), a pregnancy disorder that can have devastating effects on the health of the mother and the unborn baby. Affecting 5-8% of all pregnancies, pre-eclampsia is a rapidly progressive and potentially deadly condition.

Opterion is improving the quality of life of Peritoneal Dialysis (PD) patients. They have developed a novel PD solution that is glucose-free and considerably decreases the metabolic and peritoneal challenge of diabetes patients.

 

PerioTrap Pharmaceuticals GmbH is developing a completely new concept for the treatment of periodontitis, one of the most widespread infectious diseases worldwide. PerioTrap aims to eradicate the root of the disease and to ultimately restore patient confidence.

 

Startup PreComb Logo Fundraising

PreComb Therapeutics AG is developing the first point-of-care solution for clinically relevant drug testing, influencing patient-derived 3D microtissues for drug development and precision medicine. With this technology the entire process of generating a high number of drug efficacy data can be fully automated, allowing the establishment of a clinical network and a scalable razor blade business model to finally guide therapeutic decisions.

Resistell logo

Resistell’s life-saving technology is based on the detection of movement caused by living bacterial cells and provides information on which antibiotic should be used to treat the patient, and the concentration at which it should be administered.

Swiss Startup Scailyte Logo Fundraising

Scailyte’s multi-disciplinary team is applying a data-driven approach to discover novel biomarkers and develop a new generation of precision diagnostics based on single-cell data and AI.

Sedimentum AG is a healthcare and tech startup developing the first contactless solution for fall and emergency detection in healthcare. This technological protection ensures the physical safety of people who are on their own without compromising privacy.

Swiss Startup Sleepiz Logo Fundraising

Sleepiz’s diagnostic device uses millimeter wave technology, sensor fusion, and machine learning to measure vital signs in a contactless and medical grade manner at home, completely changing the way disorders like sleep apnea are diagnosed.

STIMIT develops a non-invasive medical device that enables ICU patients to breath by stimulating diaphragm contractions, therefore creating natural breath instead of pumping air into the lungs with a machine. With this new therapy, the breathing muscle remains active and strong.

 

SurgeonsLab produces a new brain microsurgical and endovascular physical simulator. The simulator trains medical residents, brain surgeons, and radiologists on a patient-specific case basis. The simulator enables surgeons to reduce surgical risks and improve higher patient safety. The simulator was validated and is on the market serving its customers.

 

OUR PARTNERS

At Hemex we are dedicated to helping startups succeed. We partner with exceptionally motivated experts from business and life sciences, providing a combined knowledge platform with a considerable potential for new businesses.

MEET THE TEAM

Healthcare Management Experts

Each of our associates can rely on several years of specialized experience in the Life Science industry. In order to support your project from its inception to a future exit, we cover a broad area of expertise, ranging from clinical, quality and regulatory operations to financial, legal and business development.

We have 3 Innosuisse Coaches in our group: 1 Lead Coach and 2 Special Coaches (Intellectual Property and Fundraising & Investor Relations), so we can offer you all the support you need under one roof.

Rafiq
Medical / Ra

Vanessa
Legal

Franziska
commercial

Samidha
clinical

Pascal
CEO

Vanja
Clinical

Arthur
Veterinary

Laurène
Clinical

Hans Zulliger Quality QP

Hans
Quality & QP

Yaozi
Communication

Juan
Digital Media

Ivana
Digital Media

Paul
President

Dr. Philipp Marchand

Philipp
IP Consultant

Brigitte
IP Consultant

Dieter
Finance

Andreas
Business Coach

Mohamed
Clinical

Beatrix
PR

Vincenzo
Clinical

Kira
Clinical

Marilyn
Facility

Valentin
Sales Scale-up

Martin
coach

Stefan
Medical Innovation

Birgit
Market Insights

Kurt
Submissions

Virginia
Grants

Senior ML Engineer / Researcher
(Sleepiz)

100% Remote

Candidate Profile

Who you are
(Minimum qualifications)
• You have a master’s degree in a quantitative discipline (e.g. physics, computer science, mathematics, computational biology)
• You have 4+ years industry (R&D) experience in designing, prototyping, and implementing scalable and reproducible end-to-end machine learning solutions (from research to production). Candidates with an academic background and a strong record in applying machine learning to real-world datasets are equally encouraged to apply
• You have expert knowledge of Python and are familiar with at least one deep learning framework (e.g. Tensorflow, Keras, PyTorch)
• You have a high degree of independence and an aversion to micromanagement
• You thrive in interdisciplinary environments and have excellent cross-team communication abilities. In particular, you are able to clearly convey technical concepts at a level appropriate for technical and non-technical audiences
• You are curious, inquisitive, collaborative, with a deep appreciation for diversity
• You are fluent in English (full professional proficiency)

Preferred qualifications
(In addition to the minimum qualifications above)
• You have a doctorate degree in a quantitative discipline (e.g. physics, computer science, mathematics, computational biology)
• You have a solid understanding of the foundational theory underlying machine learning (e.g. linear algebra, probability theory and numerical optimization)
• You have expert knowledge of at least one additional scripting languages (e.g. R) and of bash/shell scripting. Experience with hybrid R/Python frameworks and object-oriented programming is considered a plus
• You have demonstrated experience with building deep learning models (real-world project portfolio and/or publications)
• You have educated opinions about the designs of ML solutions, both from formal education as well as real-world experience. You are able to clearly and effectively expose such opinions and concepts to other team members and are a strong proponent of constructive dialogue
• You take pride in developing ML solutions and in documenting the data products you build together with the team
• You have experience with processing, analyzing and modeling sensor data/time series data
• You are familiar with cloud computing and development / test / production environments
• You are familiar with experimental design

EU/UK residents seeking a full-time remote position are strongly encouraged to apply. Sleepiz is an active proponent of gender equality in STEM. Female candidates are strongly encouraged to apply.

Responsibilities

What you will do

You will work within the data science team to devise scalable and reproducible end-to-end machine learning solutions for sleep analytics. Your main focus will be research and development, combining dynamic experimentation, a passion for details and a fail-fast attitude. You will also be responsible for translating research output to production systems, in close collaboration with the software team and
other stakeholders. Finally, given your key role within the team you will have the opportunity to mentor and inspire junior data scientists/interns.

Our Offer

Who are we?
Sleepiz AG (Ltd.) is a Zürich based startup with the aim to enable the medical community to take healthcare into the home environment. Sleepiz is the winner of the EIT Venture award (2019), Venture.ch in digital health (2019), DeVigier (2019), EU – H2020 Seal of Excellence (2019), Start Summit (2019), EIT award in digital health (2018), Innosuisse (2018), EU – H2020 SME Phase 1 (2018), silver winner in the Mass Challenge Switzerland (2017) Accelerator program and is ranked as the most promising digital health startup in Europe.

What Sleepiz offers
Sleepiz is a dynamic, interdisciplinary, highly skilled team that is passionate about sleep. They foster a fun and energetic start-up culture in a relaxed environment. As a part of their dedication to the diversity of our workforce, thei offer flexible working hours together with a high degree of self-responsibility and freedom. Sleepiz provides performance-oriented compensation and equity ownership.

How to apply

Your application

Do you feel like your skillsets match our needs?
Do you have what it takes to join our young and dynamic team?
Do you want to be part of the ground floor of a company that is going to take the sleep industry by storm?

Send over your CV and cover letter to career@sleepiz.com

For more information, visit their website HERE.

DSP Engineer Intern
(Sleepiz)

6.5 Months

Candidate Profile

Qualifications
• You are pursuing a Masters or PhD in Physics, Electrical Engineering or a related field (you need to be registered as a student in a Swiss University to be eligible)
• You have strong fundamentals in signal and systems (analysis in both continuous and discrete domains)
• You have knowledge of frequency domain algorithms (Fourier transform, wavelets transforms, etc.)
• You have a strong mathematical foundation
• You have programming experience with either Python or MATLAB
• You have a high degree of independence, while at the same time, are able to effectively collaborate cross-team
• You have excellent communication skills and are able to convey technical concepts clearly
• Experience with radar signals and multi-antenna signals (beamforming and MIMO) is a plus
• Knowledge of analog, digital and mixed circuit design is a plus
• Machine learning algorithms (SVM, Random forest, Neural networks, etc.) is a plus

Responsibilities

What you will do

Sleepiz is seeking an intern for a period of 6.5 months starting 1st October, 2020. This internship is an industry academic project with Innosuisse. You will participate in a project in collaboration between Swiss Federal Laboratories for Materials Science and Technology (EMPA) and Sleepiz.

You will work to develop robust algorithms for vital signs estimation. Your main focus will be to investigate strategies to estimate and characterize breathing and heart rate patterns for processing a doppler radar signal. You will work to implement, test, maintain, and document the best-performing algorithms in enterprise grade code, in close collaboration with the rest of the signal processing team members and other stakeholders.

Our Offer

Who are we?
Sleepiz AG (Ltd.) is a Zürich based startup with the aim to enable the medical community to take healthcare into the home environment. Sleepiz is the winner of the EIT Venture award (2019), Venture.ch in digital health (2019), DeVigier (2019), EU – H2020 Seal of Excellence (2019), Start Summit (2019), EIT award in digital health (2018), Innosuisse (2018), EU – H2020 SME Phase 1 (2018), silver winner in the Mass Challenge Switzerland (2017) Accelerator program and is ranked as the most promising digital health startup in Europe.

What Sleepiz offers
They are a dynamic, interdisciplinary, highly skilled team that is passionate about sleep. They foster a fun and energetic start-up culture in a relaxed environment. As a part of Sleepiz’s dedication to the diversity of our workforce, they offer flexible working hours together with a high degree of self-responsibility and freedom. You would have ample collaboration opportunities in a truly cross-functional team.

Salary
Total: CHF 2700 per month
(Salary: 2000 per month incl. 15% social security + 20% overhead CHF)
Sleepiz is an active proponent of gender equality in STEM. Female candidates are strongly encouraged to apply.

How to apply

Your application

Do you feel like your skillsets match our needs?
Do you have what it takes to join our young and dynamic team?
Do you want to be part of the ground floor of a company that is going to take the sleep industry by storm?

Send over your CV and cover letter to career@sleepiz.com

For more information, visit their website HERE.

Postdoctoral Scientist in In Vitro Diagnostic Image Capture and Analysis (deMello group at ETH)

100%, Zurich, temporary

Candidate Profile
The deMello group like to hear from computer scientists and/or imaging experts who are keen to gain expertise in bioengineering, IVDs and global health, and conversely from researchers who have experience in IVDs who are keen to move towards mHealth and computer science. Coding skills are essential. Previous experience writing code to automate high-throughput image capture and analysis, and in app development, are beneficial.
 
Candidates are expected to have obtained a PhD degree in a relevant science or engineering discipline. However, candidates will be judged on their overall experience, expertise and ambitions, rather than on their specific research discipline(s). Successful candidates will be part of an international research team and are expected to be highly motivated and passionate about science, engineering and global health.
Responsibilities

Job description

As a member of the deMello Group, you will work on the quantification of colorimetric data from microfluidics-based IVD devices, and on broader challenges in IVD development in the group. This represents an exciting opportunity to work at the interface of bioengineering and computer science, and the candidate will work in a diverse and dynamic group with an established interdisciplinary culture.
 

Responsabilities

  • Develop software that automates image capture, processing and data extraction from colorimetric IVDs
  • Integrate the software into an app with a user-friendly graphical user interface
  • Expertise in coding (essential)
  • Experience in software development (preferable)
  • Experience in IVD device development (preferable)
  • Experience in microfluidics engineering and imaging (preferable)
  • Work closely with our academic and industrial project partners to ensure the work progresses in line with the larger project objectives
  • Contribute to project management, including financial and time management
  • Present at internal project meetings and at international conferences
  • Write peer-reviewed publications

 

Project background

The availability of rapid IVD devices is critical for the control of infectious diseases. For example, the unavailability of widespread and rapid IVDs during the emergence of SARS-CoV-2 led to a severe lack of high-quality data in the early stages of that outbreak, which hindered critical time-sensitive interventions (e.g. test, trace, isolate). This rendered health agencies and governments powerless to stop COVID-19 becoming a global pandemic with terrible social and economic cost. In the deMello group, they have an established research activity on the development of colorimetric microfluidics-based IVD technologies targeting infectious disease. A key part of this work is in the development of the device–digital interface, where the output of an IVD is read and analyzed by a portable device (e.g. smartphone). To support the work in this area, the deMello group seeks a new team member who possess the relevant expertise and drive to make an impact in the diagnostics and global health fields.
Our Offer

The deMello Group (Prof. Dr. Andrew deMello) in the Institute for Chemical and Bioengineering at ETH Zürich is searching for a postdoctoral researcher to work on image capture and analysis of colorimetric in vitro diagnostic (IVD) devices. The aim is to develop software and an associated smartphone app that is able to yield a reliable and robust quantitation of the target analyte, based on data extracted from captured images. They invite candidates with research interests in software development and image analysis, with a passion for improving global health through new technologies. The position is fixed-term at 12 months in the first instance, with a possibility for extension.

 

They offer:

  • A multicultural and multidisciplinary research environment
  • Attractive hiring conditions
  • Access to state of the art equipment and resources
  • Strong support in career progression

 

ETH Zurich is one of the world’s leading universities specialising in science and technology. They are renowned for their excellent education, cutting-edge fundamental research, and direct transfer of new knowledge into society. Over 30,000 people from more than 120 countries find their university to be a place that promotes independent thinking and an environment that inspires excellence. Located in the heart of Europe, yet forging connections all over the world, they work together to develop solutions for the global challenges of today and tomorrow.

How to apply
Interested?

They look forward to receiving your online application with the following documents:

  • A cover letter detailing your motivation for applying, and how you meet the position requirements
  • A detailed CV including publication list and details of at least two references

Applications will be assessed continually, and a short list for interview will be drawn up on December 1st. Interviews will be held online in mid-December. We anticpate the chosen candidate starting the project in the first quarter of 2021. Please note that we exclusively accept applications submitted through our online application portal. Applications via email or postal services will not be considered.

Further information about the deMello group can be found on their website. Questions regarding the position are welcome, and should be directed to Dr Daniel Richards, daniel.richards@chem.ethz.ch (no applications).

 
 

LATEST NEWS

Our contact details

Office addresses

Hemex AG
Kasernenstrasse 30 | 4410 Liestal | Switzerland 

Hemex Germany GmbH
Marie-Curie-Str. 8 | 79539 Loerrach | Germany

Hemex, LLC
4800 Hampden Lane Suite 200 | Bethesda, MD 20814 | USA

E-Mail addresses

Hemex AG
info@hemex.ch
firstname.lastname@hemex.ch

Hemex Germany GmbH
info@hemex-germany.de
firstname.lastname@hemex-germany.de

Hemex, LLC
info@hemex-us.com
firstname.lastname@hemex-us.com

Telephone contact

Switzerland:

Mo-Fri 09:00-17:00 CET, our headquarters can be reached under (+41) 61-927-28-00.

Germany:

Mo-Fri 09:00-17:00 CET, our EU office can be reached under (+49) 1512-568-48-92.

United States of America:

Mo-Fri 9am-5pm Eastern Time, our team in Bethesda MD can be reached at (+1) 301-500-1535.

Outside business hours your call will be forwarded.

Emergencies:

24/7/365 emergency phone numbers: 

(+41) 79-833-73-30 (Switzerland) 

(+49) 1512-568-48-92 (Germany)

Accommodation

Hotel Engel: 2 min. on foot (ask for preferred HEMEX rate)

Hotel Bad Bubendorf: 10 min. by car

Send us an e-mail